VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Tuesday, December 30, 2025
Stock Comparison
CoStar Group, Inc. vs Sanofi
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
CoStar Group, Inc.
CSGP · NASDAQ
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into CoStar Group, Inc.'s moat claims, evidence, and risks.
View CSGP analysisSanofi
SAN · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: CoStar Group, Inc. leads (75 / 100 vs 74 / 100 for Sanofi).
- Segment focus: CoStar Group, Inc. has 6 segments (39% in Multifamily (Apartments.com Network)); Sanofi has 3 segments (79.8% in Pharma (Prescription Medicines)).
- Primary market structure: Oligopoly vs Oligopoly. Pricing power: Strong vs Moderate.
- Moat breadth: CoStar Group, Inc. has 9 moat types across 4 domains; Sanofi has 5 across 3.
Primary market context
CoStar Group, Inc.
Multifamily (Apartments.com Network)
Online multifamily rental marketplaces and advertising
United States
Two-sided (renters + property managers/owners)
Marketplace (subscription advertising + workflow tools)
39%
Sanofi
Pharma (Prescription Medicines)
Branded prescription pharmaceuticals (immunology, rare disease, neurology, oncology, general medicines)
Global
Patients via payers/providers and channel partners (wholesalers, pharmacies, hospitals)
Research-based drug developer, manufacturer, and marketer
79.8%
Side-by-side metrics
Moat coverage
Shared moat types
CoStar Group, Inc. strengths
Sanofi strengths
Segment mix
CoStar Group, Inc. segments
Full profile >CoStar (commercial real estate info & analytics)
Oligopoly
Information Services (lease management software + international info)
Competitive
Multifamily (Apartments.com Network)
Oligopoly
LoopNet (commercial property marketing marketplace)
Oligopoly
Residential (Homes.com + OnTheMarket)
Oligopoly
Other Marketplaces (Ten-X, Land.com, BizBuySell, etc.)
Competitive
Sanofi segments
Full profile >Pharma (Prescription Medicines)
Oligopoly
Vaccines
Oligopoly
Opella (Consumer Healthcare - Sanofi minority stake)
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.